Steve Bailey, MD, MSCIA, FACC, FACP
LSU Shreveport School of Medicine
Professor and Chairman Department of Medicine
Malcolm Feist Chair of Interventional Cardiology
Management Team
David Spencer
President & Chief Executive Officer
David Spencer is a business and civic entrepreneur with a passion for technology commercialization and economic development. An Army brat with a degree in electrical engineering, he has founded, owned, and sold multiple businesses in diverse areas including technology, agriculture, childcare, real estate, banking, and healthcare. Over the last 15 years, Spencer has invested in over 50 companies, with a particular interest in companies supporting military wounded worldwide. He is an active mentor for selected technology startups in the San Antonio area.
Spencer formed his first technology company in 1990. In 1996, he founded OnBoard Software, Inc. which grew to more than 90 employees and $17 million in annual revenue. In early 2005, Spencer sold his 100% stake in the company to MTC Technologies, Inc. for $34 million. Following the sale of OnBoard, he formed Mandelbrot Ventures, a boutique fund which invested in Texas-based seed-stage technology companies until 2008. In September 2005, Texas Gov. Rick Perry appointed Spencer to a two-year term as the inaugural chair of the Emerging Technology Fund (ETF) Advisory Committee, a statewide $200 million investment fund focused on Texas based technology startups. In 2007, he helped found The Bank of San Antonio, the first de novo bank start up in San Antonio in 22 years. The bank recently surpassed $500 Million in assets, and he remains active on its board of directors. In 2008, Spencer served a third year on the ETF Advisory Committee as a member/past chair. Also in 2008, he founded Texas Intrepid Ventures to help commercialize medical device innovations needed in response to the war in Iraq/Afghanistan.
In 2009, Spencer founded Speer Medical Devices, an unsuccessful effort to bring to market a technology to help combat medics triage and care for combat wounded. In 2011, he co-founded Prytime Medical with vascular medical device veteran Christopher Banas.
Spencer remains active in his local community and is a regular speaker, mentor and panelist. He was elected to the Comal Independent School District Board of Trustees, where he served from 2006 to 2014. His philanthropic and public service is centered on entrepreneurship, wounded warriors, public education, and The University of Texas at San Antonio. He and his wife Jennifer live in Boerne, Texas with their four sons.
Close
David Baer
Chief Military Liaison & Chief Scientific Officer
David Baer joined Prytime Medical in 2017, bringing more than 24 years of expertise in medical research and development targeting urgent challenges in trauma care. Dr. Baer served in numerous roles in military scientific leadership including leading strategic investment in device and drug development from foundational science, through clinical trials and operational assessment. As the Director of Research for the US Army Institute of Surgical Research, he led teams of scientists and physicians working together to deliver innovations in trauma care to meet urgent needs of medical teams deployed in Afghanistan and Iraq in fields as diverse as orthopedic trauma, oral maxillofacial surgery, pain control, transfusion medicine, burn care, and general surgery. Prior to leading the Institute’s research mission, he served as a primary investigator developing innovations in wound care, orthopedic trauma and burns. He has received numerous awards for this work including the Order of Military Medical Merritt, the Army Research and Development Achievement Award, Superior Civilian Service Award, the Meritorious Service Medal and the Combat Casualty Care Research Award for Excellence. He received his Bachelor’s of Science in Biology from Trinity University, and his Ph.D. in Genetics and Molecular Biology from the University of Hawaii. He and his wife Pam, live in San Antonio, Texas.
Close
Julie Burgett
Senior Vice President, Research and Product Development
Julie Burgett joined Prytime Medical in October 2018 bringing over 20 years of medical device product development experience. Having led or been part of teams that developed over 100 projects, she has commercialized numerous technologically advanced devices and therapies with two leading global medical device companies. Prior to joining Prytime, Julie was the Vice President for Global Product Research and Development, Chief Technology Officer for Arjo (formerly part of Getinge Group). At Arjo, she led over 125 R&D team members on three continents managing a large and very diverse product pipeline. Julie joined Getinge Group as part of the acquisition of the Therapeutic Support Systems division of Kinetic Concepts Inc (KCI) in 2012. Over a 15 year career with KCI, she held many positions of increasing responsibility in R&D and Quality organizations. She has developed products across the breadth of clinical care settings (Home, Long Term Care, Acute Care) with variations for global healthcare and payor models. The portfolio of product have a wide and varied technology base, providing solutions for: safe patient handling, personal hygiene, pulmonary care, wound prevention, skin microclimate management, venous thromboembolism prevention, incision management, open abdomen management, and wound healing. Prior to her career in medical device, she served as an officer in the US Air Force at the Human Systems Program Office. She holds a Master of Science in Engineering Systems Management from St Mary’s University and a Bachelor of Science in Aeronautical and Astronautical Engineering from Purdue University. Julie and her husband, Nick, live in Fair Oaks Ranch, Texas with their four amazing children.
Close
Gena Marshall
Chief Financial Officer
Gena Marshall joined Prytime Medical in October 2015, bringing over 25 years of financial and leadership experience with the Government Contracting and Banking industries, a diverse financial background and a proven record of successful financial and operations management. Prior to Prytime Medical, Marshall served as the Chief Financial Officer for Kforce Government Solutions, Inc. (KGS), guiding the company through the merger of three separate Government Contractor acquisitions and the ultimate transition of all financial activities to the parent company, Kforce, Inc. She led all critical financial management and reporting functions for KGS including responsibility for all financial reporting at the contract, business unit and corporate level; comprehensive financial analysis; strategic pricing leadership for competitive proposals; and leadership in support of financial aspects of business operations. Marshall joined KGS in December 2008 as part of KGS acquisition of dNovus RDI and was actively involved in Due Diligence activities on the sell side and corporate transition and integration activities on the buy side of the acquisition and merger of dNovus RDI. Marshall holds a Bachelor of Business Administration degree in Finance from Texas A&M University. She and her husband, David, live in Spring Branch, Texas and have four grown children as well as a son-in-law and daughter-in-law.
Close
Brian Young
Senior Vice President, Quality & Regulatory
Brian Young is a regulatory, quality, and clinical professional with 30 years of diversified work experience in the medical device and diagnostic industry. He is the former Vice President of Global Regulatory and Clinical Affairs at Kinetic Concepts, Inc. His experience includes a broad range of clinical and therapeutic areas including orthopedics, wound care, aesthetic products, in vitro diagnostics, general surgery, and cardiovascular surgery. Young brings a vast amount of FDA experience including significant face-to-face experiences with the agency. He has filed numerous global submissions for Class II and Class III devices, led federal, state and international compliance inspections, and developed quality systems from the ground up. His experience has led to authored publications in Regulatory Affairs Focus and a textbook chapter on regulatory strategy in Global Medical Device Registration. Young has led successful efforts to bring new and highly differentiated products to the US, Canada, Europe, India, China, Japan, and Brazil. His international experience includes obtaining the first approval for a new technology category in Japan and a first foreign approval for a new technology category in China. He received a Bachelor of Science degree in Medical Technology from the University of Iowa and a Master of Business Administration degree from Duke University’s Fuqua School of Business. Brian and his wife, Janet, live in Boerne, Texas with their son and daughter.
Close
Andrew Holman
Chief Commercial Officer
Andrew Holman has more than 20 years of senior management experience, including strategic development and commercial execution in medical devices, most recently as Global President, Q Medical Devices. Prior to that, he served as Chief Commercial Officer at BrainScope, a neuro trauma technology start-up where he successfully commercialized a first-of-its kind medical device. Before BrainScope, Holman served as Chief Commercial Officer for Integer Holdings Corporation (formerly Greatbatch). Holman began his medical device career with Boston Scientific Corporation in sales and grew into expanding roles with Johnson & Johnson, Smith & Nephew orthopedics and DJO Global where he served as EVP, US Commercial Businesses. He has a track record of success in driving revenue growth, profitability, and outstanding P&L management. He is also skilled at building best-in-class teams and maximizing sales force capabilities. Holman earned a BS Degree in Psychology & Business Administration from Rollins College, and has received extensive leadership training throughout his career.
Close
Board of Directors
David Spencer
President & Chief Executive Officer
David Spencer is a business and civic entrepreneur with a passion for technology commercialization and economic development. An Army brat with a degree in electrical engineering, he has founded, owned, and sold multiple businesses in diverse areas including technology, agriculture, childcare, real estate, banking, and healthcare. Over the last 15 years, Spencer has invested in over 50 companies, with a particular interest in companies supporting military wounded worldwide. He is an active mentor for selected technology startups in the San Antonio area.
Spencer formed his first technology company in 1990. In 1996, he founded OnBoard Software, Inc. which grew to more than 90 employees and $17 million in annual revenue. In early 2005, Spencer sold his 100% stake in the company to MTC Technologies, Inc. for $34 million. Following the sale of OnBoard, he formed Mandelbrot Ventures, a boutique fund which invested in Texas-based seed-stage technology companies until 2008. In September 2005, Texas Gov. Rick Perry appointed Spencer to a two-year term as the inaugural chair of the Emerging Technology Fund (ETF) Advisory Committee, a statewide $200 million investment fund focused on Texas based technology startups. In 2007, he helped found The Bank of San Antonio, the first de novo bank start up in San Antonio in 22 years. The bank recently surpassed $500 Million in assets, and he remains active on its board of directors. In 2008, Spencer served a third year on the ETF Advisory Committee as a member/past chair. Also in 2008, he founded Texas Intrepid Ventures to help commercialize medical device innovations needed in response to the war in Iraq/Afghanistan. In 2009, Spencer founded Speer Medical Devices, an unsuccessful effort to bring to market a technology to help combat medics triage and care for combat wounded. In 2011, he co-founded Prytime Medical with vascular medical device veteran Christopher Banas.
Spencer remains active in his local community and is a regular speaker, mentor and panelist. He was elected to the Comal Independent School District Board of Trustees, where he served from 2006 to 2014. His philanthropic and public service is centered on entrepreneurship, wounded warriors, public education, and The University of Texas at San Antonio. He and his wife Jennifer live in Boerne, Texas with their four sons.
Close
Bob Weinschenk
Bob Weinschenk is Co-Founder and Chief Executive Officer of What’s My Wine. WMW is an app that allows people to find their perfect wine 24/7, based on their own ratings. Bob has a proven track record as a startup-entrepreneur across multiple and diverse industries. Prior to joining WMW, Bob was Chief Executive Officer of Stanford Intellectual Property Exchange (SIPX), a highly scalable technology platform that seamlessly integrates with all aspects of the higher education ecosystem to provide an end-to-end solution to manage, distribute, and measure digital course material use. Prior to SIPX, Bob was Chief Executive Officer of SmartyPig, a social-networking enabled financial platform that encourages smart savings by allowing users to share their goals and invite friends and family to contribute.
Bob was also Co-Founder and Chief Executive Officer of Barfly Interactive Networks, provider of a powerful social medium that engages customers and benefits both bar owners and advertisers, which was recently acquired by TouchTunes Music Corporation. Before Barfly, Bob served as President and Chief Executive Officer of Britestream Networks, supplier of the highest performance commercial encryption / encryption technology in the world.
Bob was previously President and Chief Executive Officer of Pixim, Inc., a supplier of innovative semiconductors and software platforms for digital image capture and processing. Prior to Pixim, he was General Manager of the Microelectronics division of Lucent Technologies, which launched the first production rollout of 802.11 products. Prior to Lucent, Bob was General Manager of the chipset organization at Advanced Micro Devices, which he founded and built from the ground up. Bob holds a BS and MS in Electrical Engineering from the Stevens Institute of Technology.
Close
Michael Boswell
Michael Boswell currently serves as the partner and president of BriarPatch Partners, L.P. Founded in 2015, BriarPatch has invested in opportunistic real estate purchases and corporate investments with appreciation potential to date. Previously, Boswell served as Senior Vice President of Hunt Consolidated, Inc. where he initially directed and assisted in the start-up of an alternative energy subsidiary concentrating in wind and hydroelectric projects. He later led the effort to acquire 300,000 acres of potash mineral resources in Arizona. From 1998 to 2008, Boswell served as Principal of TBP Investments Management, LLC. He was the Owner of Fish Traders of Texas, L.P. and served as its Principal from 1993 to 1998. From 1976 to 1993, he served as Chief Executive Officer, President and Chairman of Sunshine Mining Company. Boswell began his career as a lawyer with a Dallas law firm and served at New York Stock Exchange and member firms as Senior Vice President and General Counsel of du Pont Glore Forgan from 1972 to 1974 and Executive Vice President, Chief Operating Officer and Director of Great Western United Corporation from 1974 to 1977.
From 1977 to 1979, Boswell served as Chairman of a London-based commodity merchant firm. He has been Director of Sixx Holdings, Inc. and Panda Ethanol, Inc. since April 1988 and November 2006, respectively. For Panda Ethanol, Inc., Boswell serves as Chairman of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee. Previously, Boswell served as Member of the New York Coffee and Sugar Exchange. He received a Juris Doctor degree and a Bachelor of Business Administration degree from Southern Methodist University, and he holds an Associate degree from Marion Military Institute.
Close
Michael Dupont
Accomplished Vice President of New Business Development (M&A, Divestments, Strategic Alliances), Corporate Strategy, & Global Marketing with more than 21 years of Medical Device, Life Science, and Bio-Pharmaceutical experience. Extensive track record of success in a variety of senior management, global marketing (upstream & downstream), product management, business development, strategy, and sales positions. Recognized for effectively leading teams and developing people, creating and executing strategic business plans, developing and executing successful new product launch campaigns, identifying, assessing, and executing new business development opportunities including acquisition, divestments, licensing, and distribution opportunities. Michael is currently the Vice President of NBD (M&A, Divestments, Partnerships) within Getinge Group’s Acute Care Therapies business area. His past companies include Atrium Medical Corporation, Pfizer, and Waters Corporation. Michael received his science degree with distinction from Worcester Polytechnic Institute and continues his educational learnings through various programs at Harvard Business School, Wharton Business School, and Copenhagen Business School.
Close
Bob Di Silvio
Bob Di Silvio is President of S-Force LLC; a Revenue, Process & Performance Improvement company. Prior to this Bob was President of Xtant Medical Inc.; a world leading Biologics, Spine and Orthopedic company; Senior Vice President of Lumenis North America, the world’s leading Laser and light-based medical products company. Bob previously served in a variety of senior executive positions including President & Chief Executive Officer for Pyng Medical. He also served as Vice President & General Manager with Safe Life Corp.; Vice President of US Field Operations ($300M+) for the Physio-Control division of Medtronic, the leading manufacturer of cardiac biomedical devices. In addition to a Masters in Biochemistry and a Bachelor of Arts in Economics and Organic Chemistry from the University of Connecticut, Bob also completed four years at the University of Rome School of Medicine.
Close
Co-Founders
David Spencer
President & Chief Executive Officer
David Spencer is a business and civic entrepreneur with a passion for technology commercialization and economic development. An Army brat with a degree in electrical engineering, he has founded, owned, and sold multiple businesses in diverse areas including technology, agriculture, childcare, real estate, banking, and healthcare. Over the last 15 years, Spencer has invested in over 50 companies, with a particular interest in companies supporting military wounded worldwide. He is an active mentor for selected technology startups in the San Antonio area.
Spencer formed his first technology company in 1990. In 1996, he founded OnBoard Software, Inc. which grew to more than 90 employees and $17 million in annual revenue. In early 2005, Spencer sold his 100% stake in the company to MTC Technologies, Inc. for $34 million. Following the sale of OnBoard, he formed Mandelbrot Ventures, a boutique fund which invested in Texas-based seed-stage technology companies until 2008. In September 2005, Texas Gov. Rick Perry appointed Spencer to a two-year term as the inaugural chair of the Emerging Technology Fund (ETF) Advisory Committee, a statewide $200 million investment fund focused on Texas based technology startups. In 2007, he helped found The Bank of San Antonio, the first de novo bank start up in San Antonio in 22 years. The bank recently surpassed $500 Million in assets, and he remains active on its board of directors. In 2008, Spencer served a third year on the ETF Advisory Committee as a member/past chair. Also in 2008, he founded Texas Intrepid Ventures to help commercialize medical device innovations needed in response to the war in Iraq/Afghanistan. In 2009, Spencer founded Speer Medical Devices, an unsuccessful effort to bring to market a technology to help combat medics triage and care for combat wounded. In 2011, he co-founded Prytime Medical with vascular medical device veteran Christopher Banas.
Spencer remains active in his local community and is a regular speaker, mentor and panelist. He was elected to the Comal Independent School District Board of Trustees, where he served from 2006 to 2014. His philanthropic and public service is centered on entrepreneurship, wounded warriors, public education, and The University of Texas at San Antonio. He and his wife Jennifer live in Boerne, Texas with their four sons.
Close
Christopher E. Banas
Co-Founder
Christopher E. Banas is a medical device industry veteran, with extensive leadership experience in cardiovascular company start-up, financing, management, research and development, scale up, regulatory approval and commercialization. Banas has held various executive management and engineering positions at prominent large companies such as StorageTek, W.L. Gore & Associates, Advanced Cardiovascular Systems/Guidant, Impra/C.R. Bard and Volcano Corporation. Banas has more than 35 years of product/process development experience resulting in the FDA and/or EU CE mark approval of over ten product families encompassing more than a hundred individual products, which were subsequently commercialized.
Banas co-founded five medical device companies, Advanced Bio Prosthetic Surfaces, Ltd. (ABPS), CardioSpectra, Inc, Aeon BioScience Inc., Bio2 Medical, Inc. and Prytime Medical. He is currently the President and CEO of Bio2 Medical the developer of the Angel® Catheter. The Angel® Catheter was approved by the FDA for the first ever prophylactic indication for the prevention of clinically significant pulmonary embolism (PE) in critically ill patients at high-risk for PE and contraindicated for anticoagulation and is now commercially available throughout the U.S.
Banas holds 72 issued US patents and currently has 74 published US applications in the fields of cardiovascular medicine, specifically, vascular surgery, interventional cardiology, nanotechnology and physical vapor deposition of Nitinol. Intellectual property portfolios developed by Banas have, in part, resulted in deals valued in excess of $300 million dollars, not including the value of future royalty income.
Banas also has extensive experience in life-science investing. Banas is a managing partner for Incyte Venture’s San Antonio-based Targeted Technology Fund I, and previously an advisor for the Dallas-based Scientific Health Development Fund. Banas has sat on a number of corporate boards, including serving as the Chairman of the Board for Resonetics, a New Hampshire-based excimer laser company supporting the medical device industry, and as a Director at Palmaz Scientific, a medical device company specializing in interventional cardiology products.
Close
Clinical Advisory Board
Jeffrey Cain,
MD, FACEP
Emergency Medicine Physician
Former US Army Ranger Physician; advisor to Committee on Tactical Combat Casualty Care and Committee for Tactical Emergency Casualty Care
Jonathan L. Eliason,
MD
University of Michigan
Medical Director – Diagnostic Vascular Labs
Associate Professor of Vascular Surgery
Co-Director Aortic Program
Charles “Chuck” J. Fox,
MD, FACS
University of Colorado
Chief of Vascular Surgery at Denver Health Medical Center
Former Combat Medic
Paul T. Mayer,
MD, MBA, FACEP
Emergency Physician
US Army Retired
Former US Army EMS Medical Director, Former Director US Army Center for Prehospital Medicine
Jonathan Morrison, MB CHB, PHD, FRCS
University of Maryland Medical Center
R Adams Cowley Shock Trauma Center, Professor of Vascular Surgery
Comments are closed.